Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperadrenalism
ADR ID BADD_A07296
ADR Hierarchy
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.01      Adrenal cortical hyperfunctions
05.01.01.005      Hyperadrenalism
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC
14.11.01.028      Hyperadrenalism
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.04      Endocrine and metabolic secondary hypertension
24.08.04.003      Hyperadrenalism
Description Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM. [MeSH]
MedDRA Code 10020562
MeSH ID D000308
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hyperadrenalism | Hyperplasia adrenal | Other corticoadrenal overactivity | Adrenocortical Hyperfunction | Hyperfunction, Adrenocortical | Hypercorticism | Hyperadrenocorticism | Adrenal Gland Hyperfunction | Hyperfunction, Adrenal Gland
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01557Nevirapine0.018233%
BADD_D01804Posaconazole0.021671%
BADD_D02522Lithium citrate-
The 1th Page    1    Total 1 Pages